Evidence that circulating immune complexes remove transfused platelets from the circulation.

Abstract:

:Fifteen recently diagnosed patients with acute leukemias admitted for induction chemotherapy were selected for study. When thrombocytopenic (venous platelet count less than 20 X 10(9)/l) these patients received prophylactic platelet transfusions. A total of 67 platelet transfusion therapies were administered and evaluated. Using the Raji cell radioimmunoassay, the serum concentrations of circulating immune complexes (CIC) were measured immediately before and 10-12 hr after each platelet transfusion. In 36 instances, elevated values of CIC were present in the recipient's pretransfusion samples. The corresponding posttransfusion values being significantly lower (P less than 0.05). Furthermore, in those 36 instances the mean percentage for the posttransfusion platelet increment was significantly lower (P less than 0.001) than in the remaining 31 instances in which normal pretransfusion values of CIC were measured. We conclude that CIC were an important factor in rapidly removing transfused platelets from the circulation, thereby, adversely affecting the benefit of platelet transfusions.

journal_name

Am J Hematol

authors

Kutti J,Zaroulis CG,Safai-Kutti S,Dinsmore RE,Day NK,Good RA

doi

10.1002/ajh.2830110305

subject

Has Abstract

pub_date

1981-11-01 00:00:00

pages

255-9

issue

3

eissn

0361-8609

issn

1096-8652

journal_volume

11

pub_type

杂志文章
  • Disturbance of plasma and platelet thrombospondin levels in sickle cell disease.

    abstract::Thrombospondin (TSP), a large protein found in platelet alpha-granules (as TSP-1), mediates adhesion of sickle reticulocytes to cultured vascular endothelium. To further explore the physiologic relevance of this observation, we have measured plasma TSP levels and platelet TSP-1 content in subjects with sickle cell dis...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(SICI)1096-8652(199604)51:4<296::AID-AJH8>

    authors: Browne PV,Mosher DF,Steinberg MH,Hebbel RP

    更新日期:1996-04-01 00:00:00

  • The first two Japanese cases of severe type I congenital plasminogen deficiency with ligneous conjunctivitis: successful treatment with direct thrombin inhibitor and fresh plasma.

    abstract::A 71-year-old woman and her elder sister developed ligneous conjunctivitis after ocular surgery. Laboratory tests demonstrated that the proband and her sister had 6.6% and 8.1% of plasminogen activity, and 1.2 and 1.4 mg/dl of antigen, respectively. Thus, they were diagnosed as having severe type I plasminogen deficie...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21402

    authors: Suzuki T,Ikewaki J,Iwata H,Ohashi Y,Ichinose A

    更新日期:2009-06-01 00:00:00

  • Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients.

    abstract::Although standard clinical prognostic factors predict outcome in diffuse large B-cell lymphoma (DLBCL), predicting the outcome of patients might be further refined using biological factors. We tested whether serum cytokines could provide prognostic information in DLBCL patients. Thirty cytokines were measured in pretr...

    journal_title:American journal of hematology

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/ajh.23259

    authors: Ansell SM,Maurer MJ,Ziesmer SC,Slager SL,Habermann TM,Link BK,Witzig TE,Macon WR,Dogan A,Cerhan JR,Novak AJ

    更新日期:2012-09-01 00:00:00

  • B-cell chronic lymphocytic leukaemia: prognostic value of the immunophenotype and the clinico-haematological features.

    abstract::Sixty-two previously untreated patients with B-cell chronic lymphocytic leukaemia were analysed to study the prognostic value of both the immunologic phenotype and the clinicobiologic characteristics. Univariate studies showed that none of the immunological markers analysed, sheep-rosette, mouse-rosette, slg, and HLA/...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830310105

    authors: Orfao A,Gonzalez M,San Miguel JF,Rios A,Canizo MC,Hernandez J,Maricato ML,Lopez Borrasca A

    更新日期:1989-05-01 00:00:00

  • Effect of a single ingestion of alcohol on iron absorption.

    abstract::The effect of alcohol on inorganic and organic iron absorption was studied in 70 subjects, using a whole-body counter technique. The mean iron absorption of a test dose was 24.44%, while in the presence of whisky, absorption fell to 9.73% (P less than 0.0001). Absorption of a test dose in the presence of whisky withou...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830050307

    authors: Celada A,Rudolf H,Donath A

    更新日期:1978-01-01 00:00:00

  • CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.

    abstract::Thirty-seven patients with chronic phase chronic myeloid leukaemia and fourteen healthy controls have been evaluated for lineage differentiation with immunological markers on purified bone marrow CD34 positive cells by multiparameter flow cytometry. The myeloid-associated antigen CD33 and the stem cell factor receptor...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199907)61:3<178::aid-ajh4>

    authors: Martín-Henao GA,Quiroga R,Sureda A,García J

    更新日期:1999-07-01 00:00:00

  • Chronic lymphoproliferative disorder with regulatory T-cell phenotype.

    abstract::We report a case of T-cell chronic lymphoproliferative disorder (CLPD) that shows neither features of T-cell prolymphocytic leukemia nor disease progression for more than 34 months. Flow cytometric analyses of the lymphocytes revealed high expression of CD4 and CD25. Up-regulation of Foxp3, a master regulatory gene fo...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20688

    authors: Kikuchi T,Katayama Y,Kubonishi S,Watanabe T,Watanabe Y,Matsuoka K,Maeda Y,Namba N,Masunari T,Nasu R,Ikeda K,Tanimoto M

    更新日期:2006-09-01 00:00:00

  • An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer.

    abstract::Chimeric antigen receptor (CAR) T-cell therapy represents a major advancement in personalized cancer treatment. In this strategy, a patient's own T cells are genetically engineered to express a synthetic receptor that binds a tumor antigen. CAR T cells are then expanded for clinical use and infused back into the patie...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.25418

    authors: Feins S,Kong W,Williams EF,Milone MC,Fraietta JA

    更新日期:2019-05-01 00:00:00

  • Factor VIII and IX gene polymorphisms and carrier analysis in Indian population.

    abstract::The efficacy of the three common intra- and extragenic polymorphic sites of the factor VIII and IX genes has been examined in the Indian population, with an aim to develop a strategy that would be accurate and informative, yet economical. The approach for hemophilia A carrier detection includes tests for BclI, XbaI, a...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199704)54:4<271::aid-ajh2>

    authors: Shetty S,Ghosh K,Pathare A,Colah R,Badakare S,Mohanty D

    更新日期:1997-04-01 00:00:00

  • Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studies.

    abstract::In HIV-positive patients with non-Hodgkin lymphoma (NHL), no benefit of adding rituximab to chemotherapy was seen in a randomized controlled trial (RCT). We performed a meta-analysis of prospective studies to ascertain outcomes in HIV-positive NHL patients treated with chemotherapy (chemo) versus rituximab and chemo (...

    journal_title:American journal of hematology

    pub_type: 杂志文章,meta分析

    doi:10.1002/ajh.22275

    authors: Castillo JJ,Echenique IA

    更新日期:2012-03-01 00:00:00

  • Coincidental polycythemia vera and multiple myeloma: case report and review.

    abstract::Polycythemia vera (PCV) and multiple myeloma are both clonal disorders of hematopoietic stem cells. The simultaneous occurrence of these diseases in an individual patient is rare. A case of synchronous PCV and smoldering myeloma is presented and the literature is reviewed. The issues of clinical importance in this unu...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.2830440311

    authors: Fink L,Bauer F,Perry JJ

    更新日期:1993-11-01 00:00:00

  • Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.

    abstract::Mantle cell lymphoma (MCL) is a unique type of lymphoma with a prognosis intermediate between indolent and aggressive types. The purpose of this study was to study blood cytokine levels in newly diagnosed and relapsed MCL patients with respect to patterns of abnormalities and relationship to the MCL International Prog...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.23838

    authors: Sonbol MB,Maurer MJ,Stenson MJ,Allmer C,LaPlant BR,Weiner GJ,Macon WR,Cerhan JR,Witzig TE,Gupta M

    更新日期:2014-12-01 00:00:00

  • Correlation between mutations in p53 gene and protein expression in human lymphomas.

    abstract::A discordance between p53 protein overexpression and the presence of mutations in the gene has been observed in many types of tumors, including human lymphomas. To probe this finding, we have studied a large series of 94 lymphomas of different pathologic types and histologic differentiation. Analyzing exons 5-9, we ha...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(sici)1096-8652(199705)55:1<1::aid-ajh1>3.

    authors: Martinez-Delgado B,Robledo M,Arranz E,Infantes F,Echezarreta G,Marcos B,Sanz C,Rivas C,Benitez J

    更新日期:1997-05-01 00:00:00

  • Intravenous immunoglobulin therapy results in post-infusional hyperproteinemia, increased serum viscosity, and pseudohyponatremia.

    abstract::Intravenous immunoglobulin (IVIG) therapy is associated with rare reports of thromboembolic events and severe hyponatremia. We hypothesized that IVIG therapy may result in hyperproteinemia, increased serum viscosity, and pseudohyponatremia. We conducted a prospective observational study to evaluate the incidence of hy...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10325

    authors: Steinberger BA,Ford SM,Coleman TA

    更新日期:2003-06-01 00:00:00

  • HTLV-I-seronegative, genome-positive adult T-cell leukemia: report of a case.

    abstract::An HTLV-I-seronegative case of adult T-cell leukemia (ATL) carrying the HTLV-I genome is reported. Screening serological tests were negative and Western blot analysis revealed only a faint band for HTLV-I p24. Polymerase chain reaction (PCR) disclosed the presence of HTLV-I gag, pol, env, pX, and LTR sequences in the ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/(SICI)1096-8652(199610)53:2<133::AID-AJH13

    authors: Kubota T,Ikezoe T,Hakoda E,Sawada T,Taguchi H,Miyoshi I

    更新日期:1996-10-01 00:00:00

  • Successful treatment of high titer inhibitors in mild hemophilia A with avoidance of factor VIII and immunosuppressive therapy.

    abstract::We describe two patients with mild hemophilia A (MHA) who developed high titer inhibitor (HTI) following intensive recombinant factor VIII (rFVIII) concentrate replacement for surgery and trauma. Intranasal desmopressin was instituted shortly following immunosuppressive therapy (IST) and activated prothrombin complex ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.1176

    authors: Robbins D,Kulkarni R,Gera R,Scott-Emuakpor AB,Bosma K,Penner JA

    更新日期:2001-11-01 00:00:00

  • Clinical presentation of severe anemia in pediatric patients with sickle cell anemia seen in Enugu, Nigeria.

    abstract::Anemia is a major cause of morbidity and mortality among patients with sickle cell anemia. In this study, 108 episodes of severe anemia were prospectively evaluated in 108 patients with hemoglobin SS disease attending the pediatric sickle cell clinic of the University of Nigeria Teaching Hospital, Enugu, Nigeria. Youn...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10285

    authors: Juwah AI,Nlemadim A,Kaine W

    更新日期:2003-03-01 00:00:00

  • Early lymphopenia as a risk factor for chemotherapy-induced febrile neutropenia.

    abstract::Febrile neutropenia (FN) is a frequent complication of cancer chemotherapy, which causes death in 4-21% of patients and worsens the quality of life of patients. As a simple and accurate way of identifying patients who are at risk of FN, a lymphocyte count on post-chemotherapy day 5 was suggested. To confirm the feasib...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10363

    authors: Choi CW,Sung HJ,Park KH,Yoon SY,Kim SJ,Oh SC,Seo JH,Kim BS,Shin SW,Kim YH,Kim JS

    更新日期:2003-08-01 00:00:00

  • Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study.

    abstract::A risk score based on three biological features (CD38, ZAP-70, and IGHV mutational status) was previously developed to predict progression-free survival (PFS) in untreated Binet A CLL patients. Here we perform a score validation analysis in a prospective and independent cohort of patients. Biological markers (CD38, ZA...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1002/ajh.23729

    authors: Gentile M,Cutrona G,Mosca L,Matis S,Fabris S,Lionetti M,Ilariucci F,Zupo S,Musolino C,Levato L,Molica S,Di Raimondo F,Vincelli I,Di Rienzo N,Pesce EA,Angrilli F,Federico M,Neri A,Ferrarini M,Morabito F

    更新日期:2014-07-01 00:00:00

  • Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

    abstract::Two patients underwent allogeneic hematopoietic stem cell transplantation (HSCT) for acute myeloid leukemia. Chronic graft-versus-host disease (GVHD) developed, with persistent symptomatic oral lesions. At 2 and 6 years post-HSCT, both patients developed squamous cell carcinoma (SCC) of the tongue in areas previously ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20160

    authors: Szeto CH,Shek TW,Lie AK,Au WY,Yuen AP,Kwong YL

    更新日期:2004-10-01 00:00:00

  • Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and management.

    abstract:DISEASE OVERVIEW:Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in one or more extracutaneous organs. DIAGNOSIS:The major criterion is presence of multifocal clusters of morphologically abnormal MC in the bone marrow. Minor diagnostic criteria include elevated serum tryptase...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.23459

    authors: Pardanani A

    更新日期:2013-07-01 00:00:00

  • Prognostic factors for therapeutic outcome of diffuse small non-cleaved cell lymphoma in adults.

    abstract::Most reports of prognosis and therapy in diffuse small non-cleaved cell lymphoma (DSNCL), an aggressive high-grade non-Hodgkin's lymphoma (NHL) which appears to be of two histopathologic subtypes, have included predominantly a pediatric population and very few adults. We studied 20 newly diagnosed, previously untreate...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830460408

    authors: Morrison VA,Frizzera G,Arthur DC,Ogle KM,Hurd DD,Bloomfield CD,Peterson BA

    更新日期:1994-08-01 00:00:00

  • First-line treatment of 102 chronic myeloid leukemia patients with imatinib: a long-term single institution analysis.

    abstract::Imatinib mesylate radically changed the natural history of chronic myeloid leukemia (CML). The recent availability of alternative tyrosine kinase inhibitors (TKIs) renders the clinical management of CML more complex. In this article, we summarize our long-term single institution experience. From 2003 to 2012, 102 pati...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/ajh.23804

    authors: Viganò I,Di Giacomo N,Bozzani S,Antolini L,Piazza R,Gambacorti Passerini C

    更新日期:2014-10-01 00:00:00

  • Warfarin reversal emerging as the major indication for fresh frozen plasma use at a tertiary care hospital.

    abstract::Because of the increase in the use of warfarin in the population in recent years, reversal of warfarin-related coagulopathy has become common in daily hospital practice. Transfusion of fresh frozen plasma (FFP) is the preferred treatment method for urgent warfarin reversal in the USA. We have undertaken a 1-month audi...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20902

    authors: Ozgonenel B,O'Malley B,Krishen P,Eisenbrey AB

    更新日期:2007-12-01 00:00:00

  • High NPM1 mutant allele burden at diagnosis correlates with minimal residual disease at first remission in de novo acute myeloid leukemia.

    abstract::Acute myeloid leukemia (AML) with mutated NPM1 is a newly recognized separate entity in the revised 2016 WHO classification, and is associated with a favorable prognosis. While previous studies have evaluated NPM1 in a binary fashion, we recently demonstrated a significant independent negative prognostic effect of hig...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.25544

    authors: Patel SS,Pinkus GS,Ritterhouse LL,Segal JP,Dal Cin P,Restrepo T,Harris MH,Stone RM,Hasserjian RP,Weinberg OK

    更新日期:2019-08-01 00:00:00

  • High-dose methylprednisolone is an alternative treatment for adults with autoimmune thrombocytopenic purpura refractory to intravenous immunoglobulins and oral corticosteroids.

    abstract::Eight patients with severe chronic autoimmune thrombocytopenic purpura (AITP) refractory to high-dose intravenous immunoglobulin (IVIgG) and/or oral prednisone were treated with one to three infusions of high-dose methylprednisolone (HDMP) (15 mg/kg/day). The mean platelet count before treatment was 12 +/- 10 x 10(9)/...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830480416

    authors: Godeau B,Zini JM,Schaeffer A,Bierling P

    更新日期:1995-04-01 00:00:00

  • Haplotypes and levels of fetal hemoglobin and G gamma to A gamma ratios in Mediterranean patients with thalassemia minor and major.

    abstract::This study concerned the gamma chain composition of Hb F and the haplotypes of 44 patients with beta-thalassemia major or intermedia and many of their relatives. Seventeen patients came from Northern (Turkish) Cyprus, 12 from the Istanbul area, and 15 from Macedonia and Bulgaria. Analysis of the A gamma T-G gamma-A ga...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830200103

    authors: Aksoy M,Kutlar A,Efremov GD,Nikolov N,Petkov G,Reese AL,Harano T,Chen SS,Huisman TH

    更新日期:1985-09-01 00:00:00

  • Management of acute chest wall sickle cell pain with nebulized morphine.

    abstract::This paper describes, for the first time, the utilization of nebulized morphine in the management of severe chest pain in two young adult African-American patients who suffered from generalized acute sickle cell painful episodes. While hospitalized, both patients developed new sharp chest wall pain, and were treated w...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20064

    authors: Ballas SK,Viscusi ER,Epstein KR

    更新日期:2004-06-01 00:00:00

  • Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.

    abstract::Limited data are available regarding optimal treatment with desmopressin (DDAVP) or intermediate-purity FVIII concentrates rich in VWF (CFCs) in patients with von Willebrand disease (VWD) who undergo planned surgery. We undertook a retrospective review over 10 years (1988-1997) and identified 27 patients treated with ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.1058

    authors: Nitu-Whalley IC,Griffioen A,Harrington C,Lee CA

    更新日期:2001-04-01 00:00:00

  • Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

    abstract::In a phase II trial, we evaluated chlorambucil and rituximab (CLB-R) as first-line induction treatment with or without R as maintenance for elderly chronic lymphocytic leukemia (CLL) patients. Treatment consisted of eight 28-day cycles of CLB (8 mg/m(2) /day, days 1-7) and R (day 1 of cycle 3, 375 mg/m(2) ; cycles 4-8...

    journal_title:American journal of hematology

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/ajh.23668

    authors: Foà R,Del Giudice I,Cuneo A,Del Poeta G,Ciolli S,Di Raimondo F,Lauria F,Cencini E,Rigolin GM,Cortelezzi A,Nobile F,Callea V,Brugiatelli M,Massaia M,Molica S,Trentin L,Rizzi R,Specchia G,Di Serio F,Orsucci L,Ambros

    更新日期:2014-05-01 00:00:00